| Product NDC: | 0093-2059 |
| Proprietary Name: | Nifedipine |
| Non Proprietary Name: | Nifedipine |
| Active Ingredient(s): | 90 mg/1 & nbsp; Nifedipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0093-2059 |
| Labeler Name: | TEVA PHARMACEUTICALS USA |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076070 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20121126 |
| Package NDC: | 0093-2059-01 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-2059-01) |
| NDC Code | 0093-2059-01 |
| Proprietary Name | Nifedipine |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0093-2059-01) |
| Product NDC | 0093-2059 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nifedipine |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20121126 |
| Marketing Category Name | ANDA |
| Labeler Name | TEVA PHARMACEUTICALS USA |
| Substance Name | NIFEDIPINE |
| Strength Number | 90 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |